Trial intelligence / Profile preview

Sildenafil for negative symptoms of schizophrenia

IRCT1138901151556N11Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of sildenafil in schizophrenia, sponsored by Tehran University of Medical Sciences. Started Mar 2010; status: completed.

02

Drugs

sildenafil
03

Conditions

schizophrenia

Beyond the preview

Go deeper on IRCT1138901151556N11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT1138901151556N11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call